Latest News About Mounjaro (2.5 Mg /0.5 Ml)

Updated 2026-04-27 21:03

I don’t have live access to current news right now. Here’s how you can quickly verify the latest on Mounjaro (tirzepatide) 2.5 mg/0.5 mL:

If you’d like, I can perform a focused web search and summarize the most recent statements with citations.

Sources

This label may not be the latest approved by FDA. For current ...

majority of reports of nausea, vomiting, and/or diarrhea occurred during dose escalation and decreased over time. The following gastrointestinal adverse reactions were reported more frequently in MOUNJARO-treated patients than placebo-treated patients (frequencies listed, respectively, as: placebo; 5 mg; 10 mg; 15 mg): eructation (0.4%, 3.0%,

www.accessdata.fda.gov